The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy
Open accessAbstract
FLASH radiotherapy is the delivery of ultra-high dose rate radiation several orders of magnitude higher than what is currently used in conventional clinical radiotherapy, and has the potential to revolutionize the future of cancer treatment. FLASH radiotherapy induces a phenomenon known as the FLASH effect, whereby the ultra-high dose rate radiation reduces the normal tissue toxicities commonly associated with conventional radiotherapy, while still maintaining local tumor control. The underlying mechanism(s) responsible for the FLASH effect are yet to be fully elucidated, but a prominent role for oxygen tension and reactive oxygen species production is the most current valid hypothesis. The FLASH effect has been confirmed in many studies in recent years, both in vitro and in vivo, with even the first patient with T-cell cutaneous lymphoma being treated using FLASH radiotherapy. However, most of the studies into FLASH radiotherapy have used electron beams that have low tissue penetration, which presents a limitation for translation into clinical practice. A promising alternate FLASH delivery method is via proton beam therapy, as the dose can be deposited deeper within the tissue. However, studies into FLASH protons are currently sparse. This review will summarize FLASH radiotherapy research conducted to date and the current theories explaining the FLASH effect, with an emphasis on the future potential for FLASH proton beam therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Favaudon, V., Caplier, L., Monceau, V., Pouzoulet, F., Sayarath, M., Fouillade, C., Poupon, M.-F., Brito, I., Hupé, P., Bourhis, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008973 · Cited by 1,476
IL-2: The First Effective Immunotherapy for Human Cancer
Rosenberg, S. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1490019 · Cited by 1,289
Hypoxia, DNA repair and genetic instability
Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140
Combinatorial drug therapy for cancer in the post-genomic era
Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050
Montay-Gruel, P., Petersson, K., Jaccard, M., Boivin, G., Germond, J.-F., Petit, B., Doenlen, R., Favaudon, V., Bochud, F., Bailat, C., et al. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.05.003 · Cited by 692
Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species
Montay-Gruel, P., Acharya, M. M., Petersson, K., Alikhani, L., Yakkala, C., Allen, B. D., Ollivier, J., Petit, B., Jorge, P. G., Syage, A. R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901777116 · Cited by 599
Ionizing Radiation-Induced DNA Damage, Response, and Repair
Santivasi, W. L., & Xia, F. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5668 · Cited by 593
Advances in cancer immunotherapy 2019 – latest trends
Kruger, S., Ilmer, M., Kobold, S., Cadilha, B. L., Endres, S., Ormanns, S., Schuebbe, G., Renz, B. W., D’Haese, J. G., Schloesser, H., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1266-0 · Cited by 563
TGFβ is a master regulator of radiation therapy-induced antitumor immunity
Vanpouille-Box, C., Diamond, J. M., Pilones, K. A., Zavadil, J., Babb, J. S., Formenti, S. C., Barcellos-Hoff, M. H., & Demaria, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3511 · Cited by 514
Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken
Vozenin, M.-C., Hendry, J. H., & Limoli, C. L. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.04.001 · Cited by 484
Clinical translation of FLASH radiotherapy: Why and how?
Bourhis, J., Montay-Gruel, P., Gonçalves Jorge, P., Bailat, C., Petit, B., Ollivier, J., Jeanneret-Sozzi, W., Ozsahin, M., Bochud, F., Moeckli, R., et al. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.04.008 · Cited by 474
Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
Wilson, J. D., Hammond, E. M., Higgins, G. S., & Petersson, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01563 · Cited by 473
Strategies for optimizing the response of cancer and normal tissues to radiation
Moding, E. J., Kastan, M. B., & Kirsch, D. G. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4003 · Cited by 461
Montay-Gruel, P., Bouchet, A., Jaccard, M., Patin, D., Serduc, R., Aim, W., Petersson, K., Petit, B., Bailat, C., Bourhis, J., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.08.016 · Cited by 405
Holmgaard, R. B., Schaer, D. A., Li, Y., Castaneda, S. P., Murphy, M. Y., Xu, X., Inigo, I., Dobkin, J., Manro, J. R., Iversen, P. W., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0356-4 · Cited by 356
Spitz, D. R., Buettner, G. R., Petronek, M. S., St-Aubin, J. J., Flynn, R. T., Waldron, T. J., & Limoli, C. L. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.03.028 · Cited by 308
Biological effects in normal cells exposed to FLASH dose rate protons
Buonanno, M., Grilj, V., & Brenner, D. J. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.02.009 · Cited by 306
FLASH Irradiation Spares Lung Progenitor Cells and Limits the Incidence of Radio-induced Senescence
Fouillade, C., Curras-Alonso, S., Giuranno, L., Quelennec, E., Heinrich, S., Bonnet-Boissinot, S., Beddok, A., Leboucher, S., Karakurt, H. U., Bohec, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1440 · Cited by 303
Simmons, D. A., Lartey, F. M., Schüler, E., Rafat, M., King, G., Kim, A., Ko, R., Semaan, S., Gonzalez, S., Jenkins, M., et al. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.06.006 · Cited by 278
Experimental Set-up for FLASH Proton Irradiation of Small Animals Using a Clinical System
Patriarca, A., Fouillade, C., Auger, M., Martin, F., Pouzoulet, F., Nauraye, C., Heinrich, S., Favaudon, V., Meyroneinc, S., Dendale, R., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.06.403 · Cited by 267
The FLASH effect depends on oxygen concentration
Adrian, G., Konradsson, E., Lempart, M., Bäck, S., Ceberg, C., & Petersson, K. (2020) · The British Journal of Radiology · doi:10.1259/bjr.20190702 · Cited by 245
Tumor-reprogrammed resident T cells resist radiation to control tumors
Arina, A., Beckett, M., Fernandez, C., Zheng, W., Pitroda, S., Chmura, S. J., Luke, J. J., Forde, M., Hou, Y., Burnette, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11906-2 · Cited by 229
Faster and safer? FLASH ultra-high dose rate in radiotherapy
Durante, M., Brauer-Krisch, E., & Hill, M. (2017) · The British Journal of Radiology · doi:10.1259/bjr.20170628 · Cited by 220
A mechanistic investigation of the oxygen fixation hypothesis and oxygen enhancement ratio
Robert Grimes, D., & Partridge, M. (2015) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/1/4/045209 · Cited by 188
How rapid advances in imaging are defining the future of precision radiation oncology
Beaton, L., Bandula, S., Gaze, M. N., & Sharma, R. A. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0412-y · Cited by 172
Pratx, G., & Kapp, D. S. (2019) · Physics in Medicine & Biology · doi:10.1088/1361-6560/ab3769 · Cited by 170
Managing the adverse effects of radiation therapy.
Berkey, F. J. (2010) · PubMed · Cited by 166
Neuroprotection of Radiosensitive Juvenile Mice by Ultra-High Dose Rate FLASH Irradiation
Alaghband, Y., Cheeks, S. N., Allen, B. D., Montay‐Gruel, P., Doan, N.-L., Petit, B., Jorge, P. G., Giedzinski, E., Acharya, M. M., Vozenin, M., et al. (2020) · Cancers · doi:10.3390/cancers12061671 · Cited by 161
A Quantitative Analysis of the Role of Oxygen Tension in FLASH Radiation Therapy
Petersson, K., Adrian, G., Butterworth, K. T., & McMahon, S. J. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.02.634 · Cited by 156
Recent advances in radiation oncology
Garibaldi, C., Jereczek‐Fossa, B. A., Marvaso, G., Dicuonzo, S., Rojas, D. P., Cattani, F., Starzyńska, A., Ciardo, D., Surgo, A., Leonardi, M. C., et al. (2017) · ecancermedicalscience · doi:10.3332/ecancer.2017.785 · Cited by 154
The Radiobiological Effects of Proton Beam Therapy: Impact on DNA Damage and Repair
Vitti, E. T., & Parsons, J. L. (2019) · Cancers · doi:10.3390/cancers11070946 · Cited by 137
Self-citationCarter, R. J., Nickson, C. M., Thompson, J. M., Kacperek, A., Hill, M. A., & Parsons, J. L. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.11.012 · Cited by 123
Self-citationZlobinskaya, O., Siebenwirth, C., Greubel, C., Hable, V., Hertenberger, R., Humble, N., Reinhardt, S. C. M., Michalski, D., Röper, B., Multhoff, G., et al. (2014) · Radiation Research · doi:10.1667/rr13464.1 · Cited by 113
Management of Radiation Toxicity in Head and Neck Cancers
Siddiqui, F., & Movsas, B. (2017) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2017.04.008 · Cited by 105
Expanding the therapeutic index of radiation therapy by normal tissue protection
Montay‐Gruel, P., Meziani, L., Yakkala, C., & Vozenin, M. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180008 · Cited by 82
Antonovic, L., Lindblom, E. K., Daşu, A., Bassler, N., Furusawa, Y., & Toma-Daşu, I. (2014) · Journal of Radiation Research · doi:10.1093/jrr/rru020 · Cited by 74
Colangelo, N. W., & Azzam, E. I. (2019) · Radiation Research · doi:10.1667/rr15537.1 · Cited by 55
Cited by
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zhang, Z., Liu, X., Chen, D., & Yu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01102-y · Cited by 670
Hypoxia signaling in cancer: Implications for therapeutic interventions
Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023) · MedComm · doi:10.1002/mco2.203 · Cited by 119
MDM2/X inhibitors as radiosensitizers for glioblastoma targeted therapy
Miles, X., Vandevoorde, C., Hunter, A., & Bolcaen, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.703442 · Cited by 40
Metadata
- Authors
- Hughes, J. R., & Parsons, J. L.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-09-05
- Volume
- 21
- Issue
- 18
- Pages
- 6492
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3083294077
- Cited by
- 267
- References
- 38
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.